BARDA

Beyond's analysis on BARDA

• 2026-08-05 — Basilea receives an additional USD 5.4 million from BARDA to continue development of its novel antibiotic Ceftibuten‑Ledaborbactam
• 2026-08-05 — Basilea secures extra $5.4M BARDA grant to advance novel antibiotic ceftibuten-ledaborbactam development
• 2026-07-29 — Basilea secures $30 million BARDA funding to advance Phase 3 development of its antifungal fosmanogepix

Recent news mentioning BARDA

• 2026-08-24 — Lg ridisegna la prima linea in Italia. Periti per la guida della Cassa Lombarda
• 2026-08-05 — Basilea receives additional USD 5.4 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
• 2026-08-05 — Basilea erhält zusätzliche USD 5.4 Mio. von BARDA zur Entwicklung des neuartigen Antibiotikums Ceftibuten-Ledaborbactam
• 2026-07-29 — Basilea receives USD 30 million funding under existing BARDA agreement for advancing phase 3 development of novel antifungal fosmanogepix
• 2026-07-29 — Basilea erhält im Rahmen ihrer BARDA-Vereinbarung USD 30 Mio. für die Phase-3-Entwicklung des neuen Antipilzmittels Fosmanogepix

Appears alongside

• Entwicklung
• Antibiotikums Ceftibuten-Ledaborbactam

Browse the full archive →